That was Intercept Pharmaceuticals when they got initial positive data on their NASH or cirrhosis program, if I remember right.
- Forums
- ASX - By Stock
- J&J pays 1.1B for Achillion Hep C line
That was Intercept Pharmaceuticals when they got initial...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)